Alan Wake 2 has sold over 3 million copies since its 2023 launch. Remedy CEO Jean-Charles Gaudechon has publicly said the Alan Wake and Control franchises should have sold more, and the studio is pushing IP franchising and multimedia expansion.
Alan Wake's current standing at Remedy is defined less by its own news than by the numbers around it. In May 2026, new CEO Jean-Charles Gaudechon told The Game Business that the studio's flagship titles, including Alan Wake and Control, underperformed commercially. He described a strategy of IP franchising and multimedia expansion meant to reach a broader audience.
Three months later, the H1 2026 financial report gave a concrete figure for Alan Wake 2: more than 3 million copies sold since its 2023 launch. The same report put Control Resonant, the upcoming sequel in the sister series, past 1.5 million wishlists ahead of its September 24 release, with pre-orders tracking well against comparable titles at the same point.
By October, Control Resonant had sold over 1 million copies in three weeks, the fastest a Remedy game has reached that mark, and faster than Alan Wake 2's roughly two-month pace. That comparison is the closest thing to a verdict on the Alan Wake series in this coverage. The franchise has a confirmed sales figure and a public admission from its CEO that the figure was not enough. Remedy's answer is to treat its franchises as a connected portfolio and push them through adaptation and franchising, with Alan Wake positioned alongside Control rather than as the studio's sole flagship.
Synthesized by Yomimono from the cited Yomimono stories below, each itself sourced, then editorially reviewed. Every fact links the story it came from.
Structured graph also available as JSON at /public/entities/alan-wake.
CC BY 4.0.
When a claim about Alan Wake was confirmed, debunked, or disputed against open-web sources. The record stays even after a claim drops off the facts list.
CONTROL Resonant has sold over 1 million copies, Remedy announced on October 16, three weeks after its September 24 launch. It is the fastest a Remedy game has hit that mark. The sequel stars Dylan Faden and swaps the transforming gun for the transforming melee weapon Aberrant. Steam reviews sit at roughly 12,000 with 91 percent positive, and the PlayStation Store rating is 4.76 out of 5 from about 9,400 ratings.
Remedy Entertainment's H1 2026 financial report shows Control Resonant has surpassed 1.5 million wishlists ahead of its September 24 release, and Alan Wake 2 has sold over 3 million copies since its 2023 launch. The studio says pre-orders are tracking well against comparable titles at the same point before release.
Remedy Entertainment's new CEO, Jean-Charles Gaudechon, told The Game Business that the studio's flagship titles underperformed commercially. He outlined a strategy of IP franchising and multimedia expansion, including the upcoming Control Resonant, to reach a broader audience.